GPIHBP1 autoantibody syndrome during interferon β1a treatment

Volume: 13, Issue: 1, Pages: 62 - 69
Published: Jan 1, 2019
Abstract
Autoantibodies against glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) cause chylomicronemia by blocking the ability of GPIHBP1 to bind lipoprotein lipase (LPL) and transport the enzyme to its site of action in the capillary lumen.A patient with multiple sclerosis developed chylomicronemia during interferon (IFN) β1a therapy. The chylomicronemia resolved when the IFN β1a therapy was discontinued. Here,...
Paper Details
Title
GPIHBP1 autoantibody syndrome during interferon β1a treatment
Published Date
Jan 1, 2019
Volume
13
Issue
1
Pages
62 - 69
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.